Soft tissue augmentation

Cutis

Volumn 78, Issue 3, 2006, Pages 165-172

  Hirsch, Ranella J ^a   Cohen, Joel L ^b  

^a Skincare Doctors   (United States)

^b AboutSkin Dermatology and DermSurgery PC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; COLLAGEN; CYMETRA; HYALURONIC ACID; SILICONE DERIVATIVE;

ACNE VULGARIS; ADIPOSE TISSUE; CUTANEOUS PARAMETERS; ESTHETIC SURGERY; HUMAN; PATHOLOGY; REVIEW; RHYTIDOPLASTY; SCAR; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSPLANTATION;

ACNE VULGARIS; ADIPOSE TISSUE; BIOCOMPATIBLE MATERIALS; CICATRIX; COLLAGEN; COSMETIC TECHNIQUES; HUMANS; HYALURONIC ACID; INJECTIONS, SUBCUTANEOUS; RHYTIDOPLASTY; SILICONES; SKIN AGING;

EID: 33749344145     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Solish N, Pollack SV. Approaches to acne scarring: a review. J Cutan Med Surg. 1998;2(suppl 3):24-32.
2. Krauss MC. Recent advances in soft tissue augmentation. Semin Cutan Med Surg. 1999;18:119-127.
3. Allen O. Response to subdermal implantation of texturized microimplants in humans. Aesthetic Plast Surg. 1992;16:227-230.
4. Hirsch RJ, Lewis AB. Treatment of acne scarring. Semin Cutan Med Surg. 2001;20:190-198.
5. Bailin MD, Bailin PM. Case studies: correction of surgical scars, acne scars, and rhytids with Zyderm and Zyplast implants. J Dermatol Surg Oncol. 1988;14(suppl 1):31-34.
6. DeLustro F, Mackinnon V, Swanson NA. Immunology of injectable collagen in human subjects. J Dermatol Surg Oncol. 1988;14(suppl 1):49-55.
7. Elson ML. The role of skin testing in the use of collagen injectable materials. J Dermatol Surg Oncol. 1989;15: 301-303.
8. Klein AW. Bonfire of the wrinkles. J Dermatol Surg Oncol. 1991;17:543-544.
9. Klein AW. Tissue fillers [letter]. J Drugs Dermatol. 2003;2:617.
10. Fagien S. Facial soft-tissue augmentation with injectable autologous and allogeneic human tissue collagen matrix (autologen and dermalogen). Plast Reconstr Surg. 2000;105:362-373; discussion 374-375.
11. Burres S. Preserved paniculate fascia lata for injection: a new alternative. Dermatol Surg. 1999;25:790-794.
12. Burres S. Soft-tissue augmentation with Fascian. Clin Plast Surg. 2001;28:101-110.
13. Larsen NE, Pollack CT, Reiner K, et al. Hylan gel biomaterial: dermal and immunologic compatibility. J Biomed Mater Res. 1993;27:1129-1134.
14. Comper WD, Laurent TC. Physiological function of connective tissue polysaccharides. Physiol Rev. 1978;58: 255-315.
15. Meyer LJ, Stern R. Age-dependent changes of hyaluronan in human skin. J Invest Dermatol. 1994;102: 385-389.
16. Harry C. A comparison of today's treatment options for soft tissue augmentation. Skin & Aging. March 1999;3:88.
17. Duranti F, Salti G, Bovani B, et al. Injectable hyaluronic acid gel for soft tissue augmentation, a clinical and histological study. Dermatol Surg. 1998;24:1317-1325.
18. Carruthers J, Carruthers A. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytids in adult female subjects: treatment of severe glabellar rhytids with a hyaluronic acid derivative compared with the derivative and BTX-A. Dermatol Surg. 2003;29:802-809.
19. Friedman PM, Mafong EA, Kauvar AN, et al. Safety data of injectable nonanimal stabilized hyaluronic acid for soft tissue augmentation. Dermatol Surg. 2002;28: 491-494.
20. Lupton JR, Alster TS. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg. 2000;26:135-137.
21. Fernández-Aceñero MJ, Zamora E, Borbujo J. Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation. Dermatol Surg. 2003;29:1225-1226.
22. Raulin C, Greve B, Hartschuh W, et al. Exudative granulomatous reaction to hyaluronic acid (Hylaform). Contact Dermatitis. 2000;43:178-179.
23. Allergan announces FDA approval of Juvéderm gel family of products for the treatment of facial wrinkles and folds [press release]. Irvine, Calif: Allergan, Inc; June 5, 2006.
24. de Cassia Novaes W, Berg A, Experiences with a new non-biodegradable hydrogel (Aquamid): a pilot study. Aesthetic Plast Surg. 2003;27:376-380.
25. Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29:588-595.
26. US Food and Drug Administration. Federal Food, Drug, and Cosmetic Act. Available at: http://www.fda.gov /opacom/laws/fdcact/fdctoc.htm. Accessed August 17, 2006.
27. Moyle G, Lysakova L, Brown S, et al. Polylactate (NewFill) injections subjectively and objectively improve appearance and reduce anxiety and depression scores in HIV positive persons with facial lipoatrophy: a randomized, open label, immediate vs. delayed therapy study. Poster presented at: 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 27-30, 2002; San Diego, California.
28. Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with Artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg. 2003;29:573-587.
29. Alcalay J, Alkalay R, Gat A, et al. Late-onset granulomatous reaction to Artecoll. Dermatol Surg. 2003;29:859-862.
30. McClelland M, Egbert B, Hanko V, et al. Evaluation of Artecoll polymethylmethacrylate implant for soft-tissue augmentation: biocompatibility and chemical characterization. Plast Reconstr Surg. 1997;100:1466-1474.
31. Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg. 2003;27: 354-356; discussion 367.
32. Rubin JP, Yaremchuk MJ. Complications and toxicities of implantable biomaterials used in facial reconstructive and aesthetic surgery: a comprehensive review of the literature. Plast Reconstr Surg. 1997;100:1336-1353.
33. Rapaport MJ, Vinnik C, Zarem H. Injectable silicone: cause of facial nodules, cellulites, ulceration, and migration. Aesthetic Plast Surg. 1996;20:267-276.
34. Brody HJ. Complications of expanded polytetrafluoroethylene (e-PTFE) facial implant. Dermatol Surg. 2001;27:792-794.
35. Lombardi T, Samson J, Plantier F, et al. Orofacial granulomas after injection of cosmetic fillers, histopathologic and clinical study of 11 cases. J Oral Pathol Med. 2004;33: 115-120.
36. Moskowitz L. Treatment of facial hemiatrophy by transplantation of fat tissues. Med Clin. 1930;26:1472.
37. Pinski KS. Microlipoinjection and autologous collagen. Dermatol Clin. 1995;13:339-351.
38. Vita VT. Lipoinjection and aging hands. Am J Cosmet Surg. 1989;6:27-32.
39. Rohrich RJ, Sorokin ES, Brown SA. In search of improved fat transfer viability: a quantitative analysis of the role of centrifugation and harvest site. Plast Reconstr Surg. 2004;113:391-395.